10. Performance And Diligence Obligations
[…]
10.2 The Licensee agrees, after its First Commercial Sale, to make reasonable quantities of Licensed Products available to patient assistance programs in the Licensed Territory [Worldwide], to the extent commercially reasonable and without otherwise harming the business interests or viability of Licensee.
Special thanks to our supporters at Duke Law School Community Enterprise Clinic
If you are interested in providing funding or an in-kind contribution to support GHIAA’s work, please contact us using the form below.
Global Health Innovation Alliance Accelerator is a 501(c)(3) non-profit recognized by the IRS.
MAPGuideⓇ by the Global Healthcare Innovation Alliance Accelerator is licensed under CC-BY-NC-ND 4.0.
This website and the MAPGuideⓇ are provided for general informational purposes only. By using this website and any element of the MAPGuideⓇ, you agree that the information provided does not constitute legal, financial or any other form of professional advice. No relationship is created with you, nor any duty of care assumed to you, when you use this website or the MAPGuideⓇ. Neither this website nor the MAPGuide are a substitute for obtaining any legal, financial or any other form of professional advice from a suitably qualified and licensed advisor. The information provided on this website and the MAPGuideⓇ may be changed without notice and is not guaranteed to be complete, accurate, correct or up-to-date. For further information please see our Terms of Service.
Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833
Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA
© 2022 Global Healthcare Innovation Alliance Accelerator. All Rights Reserved
Def'n
Receive updates about GHIAA’s latest tools, resources and news.
